Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.38 |
| ▸ | HPGD | P15428 | 6/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL527950 | 0.70 | KDM4E (0.43) | PDGFRBPDGFRAALDH1A1KDM4EHPGD | |
| SCHEMBL5562603 | 0.68 | SRC (0.42) | PDGFRBPDGFRAALDH1A1KDM4EHPGD | |
| SCHEMBL527216 | 0.67 | ALDH1A1 (0.40) | PDGFRBPDGFRAALDH1A1KDM4EHPGD | |
| SCHEMBL7163627 | 0.66 | EGFR (0.48) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL30250019 | 0.65 | CYP3A4 (0.57) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL10638685 | 0.65 | ALDH1A1 (0.57) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL10635467 | 0.65 | CYP3A4 (0.57) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL717364 | 0.65 | CYP3A4 (0.35) | ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A | |
| SCHEMBL30682087 | 0.64 | KMT2A (0.46) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL3768019 | 0.63 | EGFR (0.49) | ALDH1A1KDM4EHPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140370121-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2014-12-18 | — | — | US | claimed |
| US-8859532-B2 | Materials and method for inhibiting replication protein A and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) | 2014-10-14 | — | — | US | claimed |
| US-20130028989-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-01-31 | — | — | US | claimed |
| EP-2531032-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | Indiana University Research and Technology Corporation (US) | 2012-12-12 | — | — | EP | claimed |
| WO-2011097545-A9 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORTION (US) | 2011-11-17 | — | — | WO | claimed |
| WO-2011097545-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORTION (US) | 2011-08-11 | — | — | WO | claimed |
| US-20100292266-A1 | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase | JANSSEN PHARMACEUTICA NV (BE) | 2010-11-18 | — | — | US | claimed |
| EP-2023728-A2 | OXAZOLYL PIPERIDINE MODULATORS OF FATTY ACID AMIDE HYDROLASE | Janssen Pharmaceutica, N.V. (BE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007140005-A2 | OXAZOLYL PIPERIDINE MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-12-06 | — | — | WO | claimed |
| EP-2531032-B1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | UNIV INDIANA RES & TECH CORP (US) | 2019-04-10 | — | — | EP | disclosed |
| US-9730942-B2 | Materials and method for inhibiting replication protein A and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-08-15 | — | — | US | disclosed |
| US-20170182055-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | UNIV INDIANA RES & TECH CORP (US) | 2017-06-29 | — | — | US | disclosed |
| US-9533969-B2 | Materials and method for inhibiting replication protein A and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-01-03 | — | — | US | disclosed |
| US-20140370121-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2014-12-18 | — | — | US | disclosed |
| EP-2531032-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | Indiana University Research and Technology Corporation (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011097545-A9 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORTION (US) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011097545-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORTION (US) | 2011-08-11 | — | — | WO | disclosed |
| US-20100292266-A1 | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase | JANSSEN PHARMACEUTICA NV (BE) | 2010-11-18 | — | — | US | disclosed |
| EP-2023728-A2 | OXAZOLYL PIPERIDINE MODULATORS OF FATTY ACID AMIDE HYDROLASE | Janssen Pharmaceutica, N.V. (BE) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007140005-A2 | OXAZOLYL PIPERIDINE MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140370121-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | RPA1, RPA3, PCNA | PDGFRB 3448/4885PDGFRA 2998/4885ALDH1A1 4306/4885 |
| US-20130028989-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | RPA1, RPA3, PCNA | PDGFRB 3448/4885PDGFRA 2998/4885ALDH1A1 4306/4885 |
| US-20100292266-A1 | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase | FAAH, FAAH2, APEH | PDGFRB 1010/4885PDGFRA 770/4885ALDH1A1 635/4885 |
| US-20170182055-A1 | MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF | RPA1, PCNA, RPA3 | PDGFRB 3574/4885PDGFRA 2971/4885ALDH1A1 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.